REG - Impax Asset Mngmnt - Director/PDMR Shareholding

Impax Asset ManagementAnnouncement

15/03/2019 16:55

RNS Number : 0829T
Impax Asset Management Group plc
15 March 2019
 


15 March 2019
Impax Asset Management Group plc
Director/PDMR Shareholding
Impax Asset Management Group plc (the "Company") was informed today that Charlie Ridge (Chief Financial Officer of the Company) has elected to participate in the Company's HMRC approved Share Incentive Plan ("SIP"). The SIP was launched in 2018, details of which are in the Company's announcement made on 11 April 2018. Mr Ridge has elected to make a deduction from his salary of a total value of £1,800, which will be used to purchase ordinary shares of 1 pence each in the Company in the open market. The purchase is expected to occur in mid-April 2019 and the Company will announce at the time details of the dealing, including the disclosure required by the EU Market Abuse Regulation.
LEI number: 213800AJDNW4S2B7E680
 
Enquiries:
Zack Wilson
Group General Counsel and Company Secretary                           Tel: +44 (0) 20 3912 3000 (switchboard)
Impax Asset Management Group plc
7th floor, 30 Panton Street
London SW1Y 4AJ                                                              
 
www.impaxam.com
 
Karen Wagg, Director of Communications                                     Tel: +44 (0) 20 3912 3142
Impax Asset Management Group plc
k.wagg@impaxam.com 
 
Gay Collins/Louis Supple
Montfort Communications                                                               Tel: + 44 (0) 7798 626282
      Tel: + 44 (0) 20 3770 7914
impax@montfort.london


Guy Wiehahn                                                                                    Tel: +44 (0) 20 7418 8893

Nominated Adviser and Broker

Peel Hunt LLP
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHLLFERVFIELIA